[go: up one dir, main page]

DK0527879T3 - Synergistiske terapeutiske præparater og fremgangsmåder. - Google Patents

Synergistiske terapeutiske præparater og fremgangsmåder.

Info

Publication number
DK0527879T3
DK0527879T3 DK91909382.3T DK91909382T DK0527879T3 DK 0527879 T3 DK0527879 T3 DK 0527879T3 DK 91909382 T DK91909382 T DK 91909382T DK 0527879 T3 DK0527879 T3 DK 0527879T3
Authority
DK
Denmark
Prior art keywords
methods
synergistic therapeutic
therapeutic preparations
preparations
synergistic
Prior art date
Application number
DK91909382.3T
Other languages
Danish (da)
English (en)
Inventor
Anthony Andrea Fossa
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24080550&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0527879(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0527879T3 publication Critical patent/DK0527879T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK91909382.3T 1990-05-11 1991-04-22 Synergistiske terapeutiske præparater og fremgangsmåder. DK0527879T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52236090A 1990-05-11 1990-05-11

Publications (1)

Publication Number Publication Date
DK0527879T3 true DK0527879T3 (da) 1997-07-14

Family

ID=24080550

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91909382.3T DK0527879T3 (da) 1990-05-11 1991-04-22 Synergistiske terapeutiske præparater og fremgangsmåder.

Country Status (34)

Country Link
US (2) US6900234B1 (ro)
EP (1) EP0527879B1 (ro)
JP (2) JPH0729938B2 (ro)
KR (1) KR970005839B1 (ro)
CN (7) CN100358578C (ro)
AP (1) AP240A (ro)
AT (1) ATE148632T1 (ro)
AU (1) AU653724B2 (ro)
BG (1) BG61831B1 (ro)
BR (1) BR9106438A (ro)
CA (1) CA2081564C (ro)
DE (1) DE69124598T2 (ro)
DK (1) DK0527879T3 (ro)
EG (1) EG19648A (ro)
ES (1) ES2097208T3 (ro)
GR (1) GR3022997T3 (ro)
GT (1) GT199100032A (ro)
HK (1) HK1094148A1 (ro)
HU (1) HU227346B1 (ro)
IE (1) IE911592A1 (ro)
IL (1) IL98055A (ro)
IS (1) IS2042B (ro)
MA (1) MA22150A1 (ro)
MY (1) MY114347A (ro)
NO (1) NO924321L (ro)
NZ (1) NZ238118A (ro)
PE (1) PE30891A1 (ro)
PT (1) PT97615B (ro)
RO (1) RO115786B1 (ro)
RU (1) RU2147875C1 (ro)
TW (1) TW203553B (ro)
WO (1) WO1991017771A1 (ro)
YU (1) YU49094B (ro)
ZA (1) ZA913539B (ro)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9106438A (pt) * 1990-05-11 1993-05-18 Pfizer Composicoes terapeuticas sinergisticas e processos
EP0629408A1 (en) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Combination of angiotensin converting enzyme inhibitors and AII antagonists
DE4340437C1 (de) * 1993-11-27 1995-05-24 Karla Dr Lehmann Verwendung von Lithiumverbindungen zur Behandlung von Herzinsuffizienz einschließlich ihrer Folgeerkrankungen
SK133897A3 (en) * 1995-04-07 1998-02-04 Ciba Geigy Ag Combination compositions containing benazepril or benazeprilat and valsartan
AU716519B2 (en) * 1995-06-30 2000-02-24 Laboratoires Merck Sharp & Dohme - Chibret Snc Method of treating renal disease using an ace inhibitor and an A II antagonist
EP1813286A3 (en) 1996-04-05 2008-04-16 Takeda Pharmaceutical Company Limited Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound
CA2257946A1 (en) * 1996-06-24 1997-12-31 Merck & Co., Inc. A composition of enalapril and losartan
US6087386A (en) * 1996-06-24 2000-07-11 Merck & Co., Inc. Composition of enalapril and losartan
AU9509798A (en) 1997-09-25 1999-04-12 University Of Florida Antisense oligonucleotide compositions targeted to angiotensi n converting enzy me mrna and methods of use
DE69808518T2 (de) * 1997-12-23 2003-06-26 Warner-Lambert Co., Morris Plains Ace hemmer/matrix metalloproteinase hemmer-arzneimittelkombinationen
US6087343A (en) * 1998-09-14 2000-07-11 University Of Florida Antisense oligonucleotides targeted to β-1 adrenoceptor and methods of use
US6387894B1 (en) * 1999-06-11 2002-05-14 Pfizer Inc. Use of CRF antagonists and renin-angiotensin system inhibitors
US8168616B1 (en) * 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
US20060013852A1 (en) * 2002-06-28 2006-01-19 Prescott Margaret F Use of organic compounds
BRPI0409133B8 (pt) 2003-04-08 2021-05-25 Progenics Pharm Inc preparações farmacêuticas estavéis compreendendo metilnaltrexona
US20040265238A1 (en) 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
ES2384637T3 (es) * 2004-10-08 2012-07-10 Novartis Ag Uso de inhibidores de la renina para la prevención o el tratamiento de disfunción diastólica o insuficiencia cardiaca diastólica
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
CA2600350C (en) * 2005-03-07 2015-02-10 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
TW200817048A (en) * 2006-09-08 2008-04-16 Wyeth Corp Dry powder compound formulations and uses thereof
CL2007002689A1 (es) 2006-09-18 2008-04-18 Vitae Pharmaceuticals Inc Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
CA2682125C (en) 2007-03-29 2015-06-16 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
BRPI0809579B8 (pt) 2007-03-29 2021-05-25 Progenics Pharm Inc formas cristalinas e seus usos
EP2139890B1 (en) 2007-03-29 2014-06-25 Wyeth LLC Peripheral opioid receptor antagonists and uses thereof
KR101581480B1 (ko) 2008-02-06 2015-12-30 프로제닉스 파머슈티컬스, 인코포레이티드 (ｒ),(ｒ)-2,2'-비스-메틸날트렉손의 제조법 및 용도
AU2009225434B2 (en) 2008-03-21 2014-05-22 The University Of Chicago Treatment with opioid antagonists and mTOR inhibitors
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
AR077692A1 (es) 2009-08-06 2011-09-14 Vitae Pharmaceuticals Inc Sales de 2-((r)-(3-clorofenil) ((r)-1-((s) -2-(metilamino)-3-((r)-tetrahidro-2h-piran-3-il) propilcarbamoil) piperidin -3-il) metoxi) etilcarbamato de metilo
CN102423483A (zh) * 2011-11-24 2012-04-25 西北农林科技大学 一种复方雷米普利纳米乳抗高血压药物
CN114032273B (zh) * 2021-11-17 2024-02-02 山东省科学院生物研究所 一种多功能西洋参水解肽及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US324377A (en) * 1885-08-18 Roller-skate
US4046889A (en) * 1976-02-13 1977-09-06 E. R. Squibb & Sons, Inc. Azetidine-2-carboxylic acid derivatives
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
JPS5671074A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
US4749688A (en) 1986-06-20 1988-06-07 Schering Corporation Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension
CA1334092C (en) 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4814342A (en) 1986-10-31 1989-03-21 Pfizer Inc. Nor-statine and nor-cyclostatine polypeptides
US4895834A (en) * 1986-12-15 1990-01-23 Warner-Lambert Company Renin inhibitors III
US4962105A (en) 1987-10-19 1990-10-09 Ciba-Geigy Corporation Potentiation of antihypertensive effect of ace inhibitors
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US5015651A (en) 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
IL91780A (en) 1988-10-04 1995-08-31 Abbott Lab History of the amine of the xenon-preventing xanine acid, the process for their preparation and the pharmaceutical preparations containing them
BR9106438A (pt) * 1990-05-11 1993-05-18 Pfizer Composicoes terapeuticas sinergisticas e processos

Also Published As

Publication number Publication date
IL98055A0 (en) 1992-06-21
HU227346B1 (en) 2011-04-28
CN1915428A (zh) 2007-02-21
PT97615A (pt) 1992-03-31
IS2042B (is) 2005-09-15
AP240A (en) 1993-02-18
EG19648A (en) 1995-09-30
YU49094B (sh) 2003-12-31
CN1307901A (zh) 2001-08-15
AU7859191A (en) 1991-12-10
IL98055A (en) 1996-10-31
AP9100258A0 (en) 1991-07-31
NO924321L (no) 1993-01-08
GR3022997T3 (en) 1997-07-30
TW203553B (ro) 1993-04-11
JPH05505618A (ja) 1993-08-19
CN1056426A (zh) 1991-11-27
CN1502370A (zh) 2004-06-09
RU2147875C1 (ru) 2000-04-27
CN1879884A (zh) 2006-12-20
HK1094148A1 (en) 2007-03-23
IS3703A7 (is) 1991-11-12
NZ238118A (en) 1997-06-24
WO1991017771A1 (en) 1991-11-28
RO115786B1 (ro) 2000-06-30
CN100358578C (zh) 2008-01-02
PT97615B (pt) 1998-08-31
DE69124598D1 (de) 1997-03-20
HU9203522D0 (en) 1993-01-28
CA2081564C (en) 1998-02-03
YU81991A (sh) 1994-06-24
JPH0729938B2 (ja) 1995-04-05
BG61831B1 (bg) 1998-07-31
BG97068A (bg) 1993-12-24
GT199100032A (es) 1992-10-31
IE911592A1 (en) 1991-11-20
CN1824315B (zh) 2011-01-12
ES2097208T3 (es) 1997-04-01
AU653724B2 (en) 1994-10-13
KR970005839B1 (ko) 1997-04-21
MA22150A1 (fr) 1991-12-31
EP0527879B1 (en) 1997-02-05
PE30891A1 (es) 1991-11-27
US6716875B1 (en) 2004-04-06
CN1065140C (zh) 2001-05-02
BR9106438A (pt) 1993-05-18
CA2081564A1 (en) 1991-11-12
JPH0748280A (ja) 1995-02-21
MY114347A (en) 2002-10-31
NO924321D0 (no) 1992-11-10
DE69124598T2 (de) 1997-05-28
HUT62804A (en) 1993-06-28
US6900234B1 (en) 2005-05-31
EP0527879A1 (en) 1993-02-24
CN1824315A (zh) 2006-08-30
JP2635291B2 (ja) 1997-07-30
ZA913539B (en) 1992-12-30
CN101156949A (zh) 2008-04-09
ATE148632T1 (de) 1997-02-15

Similar Documents

Publication Publication Date Title
DK0527879T3 (da) Synergistiske terapeutiske præparater og fremgangsmåder.
NO921012D0 (no) Farmasoeytiske preparater og deres anvendelse
NO893678D0 (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
NO943511D0 (no) Farmasöytiske preparater og anvendelse derav
FI915376L (fi) Smakaemnespreparat.
NO902658L (no) N-fenylpyrazolderivater, preparater og anvendelse derav.
DK0540609T3 (da) Cephalosporiner og homologer, fremstillinger og farmaceutiske præparater
NO912589D0 (no) Anti-plakk og anti-tannsten tannpasta.
NO922275L (no) Aryletere, deres fremstilling og fremgangsmaate for behandling
DE3873127D1 (de) Therapeutische praeparate.
NO882807L (no) Herdbare blandinger og deres anvendelse.
NO910003L (no) Vitamin e-derivater og fremgangsmaate for deres fremstilling.
DK650089A (da) Furanalkylketoner og farmaceutiske praeparater deraf
NO893474D0 (no) Flammehemmende midler og fremgangsmaate for anvendelse.
NO911047D0 (no) Labdaner og fremgangsmaate for deres fremstilling.
NO902620D0 (no) Drivstoff og brenselbehandling.
NO892676L (no) Sialinsyre-bundet oktapeptid og fremstilling derav.
NO179907C (no) Benzokinoksaliner og farmasöytiske preparater inneholdende de samme
FR2694702B3 (fr) Bracelet therapeutique perfectionne.
NO901052D0 (no) 1h-pyrazol-1-acetamider og fremstilling derav.
NO901828L (no) Poroese polymerkuler og fremgangsmaate.
NO900703D0 (no) Forbedrede herbicide preparater og deres anvendelse.
NO891942L (no) Trapp og trappetrinn.
IT8821674A0 (it) Apparato e procedimento di cottura alla griglia.
DK117091D0 (da) Utraditionel tandpleje og paradentosebehandling